Double whammy: Regulatory hurdles, one-time expenses erase half of Cipla profit
Cipla Q3 Results: Pharma major Cipla posted a massive 57% year-on-year (yoy) decline in its consolidated net profit for the third quarter of the ongoing fiscal on Friday, missing estimates. The company posted a net profit of ₹675.80 crore for Q3 FY26, as against ₹1,570.51 crore in the same period last year. Revenue from operations…